Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations

View ORCID ProfileJeremy D. Goldhaber-Fiebert, Lea Prince, Elizabeth T. Chin, View ORCID ProfileDavid Leidner, David M. Studdert, View ORCID ProfileJoshua A. Salomon, Jason R. Andrews
doi: https://doi.org/10.1101/2022.01.21.22269664
Jeremy D. Goldhaber-Fiebert
1Department of Health Policy & the Freeman Spogli Institute, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremy D. Goldhaber-Fiebert
  • For correspondence: jeremygf@stanford.edu
Lea Prince
1Department of Health Policy & the Freeman Spogli Institute, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth T. Chin
2Department of Biomedical Data Science, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Leidner
3California Department of Corrections and Rehabilitation, Sacramento, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Leidner
David M. Studdert
4Department of Health Policy, the Freeman Spogli Institute, and Stanford Law School, Stanford University, Stanford CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua A. Salomon
1Department of Health Policy & the Freeman Spogli Institute, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua A. Salomon
Jason R. Andrews
5Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

To distinguish waning of vaccine responses from differential variant protection, we performed a test-negative case-control analysis during a Delta variant-dominant period in California’s prisons. We found that infection odds increased each 28-day period post-vaccination, reaching 3.4-fold (residents) to 4.7-fold (staff) increased odds of infection after 180 days.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was supported in part by the Covid-19 Emergency Response Fund at Stanford, established with a gift from the Horowitz Family Foundation; a grant (R37-DA15612), awarded to Dr. Goldhaber-Fiebert and Dr. Salomon, from the National Institute on Drug Abuse; a grant (NU38OT000297-02), awarded to Dr. Salomon, from the Centers for Disease Control and Prevention through the Council of State and Territorial Epidemiologists; a grant (DGE-1656518), awarded to Ms. Chin, from the National Science Foundation Graduate Research Fellowship Program. The funders had no role in the study's design, conduct, or reporting, or in the publication decision.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Stanford Institution Review Board (Protocol: IRB-55835)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Supported in part by the Covid-19 Emergency Response Fund at Stanford, established with a gift from the Horowitz Family Foundation; a grant (R37-DA15612), awarded to Dr. Goldhaber-Fiebert and Dr. Salomon, from the National Institute on Drug Abuse; a grant (NU38OT000297-02), awarded to Dr. Salomon, from the Centers for Disease Control and Prevention through the Council of State and Territorial Epidemiologists; a grant (DGE-1656518), awarded to Ms. Chin, from the National Science Foundation Graduate Research Fellowship Program. The funders had no role in the study’s design, conduct, or reporting, or in the publication decision.

  • All authors declare that they have no conflicts of interest.

Data Availability

All data were shared by the California Department of Corrections and Rehabilitation under a Data Use Agreement and hence are not available.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations
Jeremy D. Goldhaber-Fiebert, Lea Prince, Elizabeth T. Chin, David Leidner, David M. Studdert, Joshua A. Salomon, Jason R. Andrews
medRxiv 2022.01.21.22269664; doi: https://doi.org/10.1101/2022.01.21.22269664
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Waning of Vaccine-Conferred Protection against SARS-CoV-2 Infection: Matched Case-Control Test-Negative Design Study in Two High-Risk Populations
Jeremy D. Goldhaber-Fiebert, Lea Prince, Elizabeth T. Chin, David Leidner, David M. Studdert, Joshua A. Salomon, Jason R. Andrews
medRxiv 2022.01.21.22269664; doi: https://doi.org/10.1101/2022.01.21.22269664

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1434)
  • Dentistry and Oral Medicine (220)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (589)
  • Epidemiology (10330)
  • Forensic Medicine (6)
  • Gastroenterology (533)
  • Genetic and Genomic Medicine (2653)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (681)
  • Hematology (269)
  • HIV/AIDS (570)
  • Infectious Diseases (except HIV/AIDS) (12119)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2483)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (497)
  • Occupational and Environmental Health (569)
  • Oncology (1333)
  • Ophthalmology (403)
  • Orthopedics (152)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (786)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2419)
  • Public and Global Health (5031)
  • Radiology and Imaging (901)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (300)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)